Sci Rep:通过深度学习对前列腺癌组织芯片的自动化格林森评分研究

2018-08-24 AlexYang MedSci原创

格林森评分系统从20世纪60年代开始一直是前列腺癌患者有利的预后预测因子。该评分系统的使用需要高强度训练过的病理学家,并且单一乏味,并且病理学家之间的重复性比较差,尤其是对那些格林森评分中等的患者重复性更差。自动化的注释程序能够为克服这些限制提供一个可行的方案。最近,有研究人员通过前列腺癌组织芯片的苏木精和伊红染色,呈现了一种自动化注释格林森评分的深度学习方法。他们的系统是使用详细的格林森注释进行

格林森评分系统从20世纪60年代开始一直是前列腺癌患者有利的预后预测因子。该评分系统的使用需要高强度训练过的病理学家,并且单一乏味,并且病理学家之间的重复性比较差,尤其是对那些格林森评分中等的患者重复性更差。自动化的注释程序能够为克服这些限制提供一个可行的方案。

最近,有研究人员通过前列腺癌组织芯片的苏木精和伊红染色,呈现了一种自动化注释格林森评分的深度学习方法。他们的系统是使用详细的格林森注释进行训练的,这些注释来源于641名患者群体,并且研究人员利用他们的系统随后对由2名病理学家注释过的245名患者进行了独立的群体测试。研究发现,模型和每位病理学家注释的一致性科恩二次Kappa统计值分别为0.75和0.71,这与病理学家之间的一致性是相当的(kappa=0.71)。进一步的是,模型的格林森评分作业能够基于测试群体的疾病特异性生存数据,能够获得病理学家专家水平的患者分层。

最后,研究人员指出,他们的研究表明了利用深度学习方法来获得更加客观和可重复性的前列腺评分是非常有前景的,尤其是对那些具有异质性格林森模式的案例。

原始出处:

Eirini Arvaniti, Kim S. Fricker, Michael Moret et al. Automated Gleason grading of prostate cancer tissue microarrays via deep learning. Sci Rep. 13 Aug 2018.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1664261, encodeId=5a7f1664261ac, content=<a href='/topic/show?id=23416231447' target=_blank style='color:#2F92EE;'>#格林森评分#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62314, encryptionId=23416231447, topicName=格林森评分)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ecb25719968, createdName=ms5353107019656438, createdTime=Sun Aug 04 02:08:00 CST 2019, time=2019-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952821, encodeId=46151952821d4, content=<a href='/topic/show?id=cca586045c8' target=_blank style='color:#2F92EE;'>#自动化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86045, encryptionId=cca586045c8, topicName=自动化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b952312, createdName=zhs3882, createdTime=Tue Jan 15 21:08:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458963, encodeId=4434145896371, content=<a href='/topic/show?id=53cc8691532' target=_blank style='color:#2F92EE;'>#芯片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86915, encryptionId=53cc8691532, topicName=芯片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf76117088, createdName=lixiaol, createdTime=Sun Aug 26 03:08:00 CST 2018, time=2018-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340550, encodeId=f40a340550f7, content=很好的学习机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Fri Aug 24 12:12:13 CST 2018, time=2018-08-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1664261, encodeId=5a7f1664261ac, content=<a href='/topic/show?id=23416231447' target=_blank style='color:#2F92EE;'>#格林森评分#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62314, encryptionId=23416231447, topicName=格林森评分)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ecb25719968, createdName=ms5353107019656438, createdTime=Sun Aug 04 02:08:00 CST 2019, time=2019-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952821, encodeId=46151952821d4, content=<a href='/topic/show?id=cca586045c8' target=_blank style='color:#2F92EE;'>#自动化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86045, encryptionId=cca586045c8, topicName=自动化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b952312, createdName=zhs3882, createdTime=Tue Jan 15 21:08:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458963, encodeId=4434145896371, content=<a href='/topic/show?id=53cc8691532' target=_blank style='color:#2F92EE;'>#芯片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86915, encryptionId=53cc8691532, topicName=芯片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf76117088, createdName=lixiaol, createdTime=Sun Aug 26 03:08:00 CST 2018, time=2018-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340550, encodeId=f40a340550f7, content=很好的学习机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Fri Aug 24 12:12:13 CST 2018, time=2018-08-24, status=1, ipAttribution=)]
    2019-01-15 zhs3882
  3. [GetPortalCommentsPageByObjectIdResponse(id=1664261, encodeId=5a7f1664261ac, content=<a href='/topic/show?id=23416231447' target=_blank style='color:#2F92EE;'>#格林森评分#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62314, encryptionId=23416231447, topicName=格林森评分)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ecb25719968, createdName=ms5353107019656438, createdTime=Sun Aug 04 02:08:00 CST 2019, time=2019-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952821, encodeId=46151952821d4, content=<a href='/topic/show?id=cca586045c8' target=_blank style='color:#2F92EE;'>#自动化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86045, encryptionId=cca586045c8, topicName=自动化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b952312, createdName=zhs3882, createdTime=Tue Jan 15 21:08:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458963, encodeId=4434145896371, content=<a href='/topic/show?id=53cc8691532' target=_blank style='color:#2F92EE;'>#芯片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86915, encryptionId=53cc8691532, topicName=芯片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf76117088, createdName=lixiaol, createdTime=Sun Aug 26 03:08:00 CST 2018, time=2018-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340550, encodeId=f40a340550f7, content=很好的学习机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Fri Aug 24 12:12:13 CST 2018, time=2018-08-24, status=1, ipAttribution=)]
    2018-08-26 lixiaol
  4. [GetPortalCommentsPageByObjectIdResponse(id=1664261, encodeId=5a7f1664261ac, content=<a href='/topic/show?id=23416231447' target=_blank style='color:#2F92EE;'>#格林森评分#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62314, encryptionId=23416231447, topicName=格林森评分)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ecb25719968, createdName=ms5353107019656438, createdTime=Sun Aug 04 02:08:00 CST 2019, time=2019-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952821, encodeId=46151952821d4, content=<a href='/topic/show?id=cca586045c8' target=_blank style='color:#2F92EE;'>#自动化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86045, encryptionId=cca586045c8, topicName=自动化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b952312, createdName=zhs3882, createdTime=Tue Jan 15 21:08:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458963, encodeId=4434145896371, content=<a href='/topic/show?id=53cc8691532' target=_blank style='color:#2F92EE;'>#芯片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86915, encryptionId=53cc8691532, topicName=芯片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf76117088, createdName=lixiaol, createdTime=Sun Aug 26 03:08:00 CST 2018, time=2018-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340550, encodeId=f40a340550f7, content=很好的学习机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Fri Aug 24 12:12:13 CST 2018, time=2018-08-24, status=1, ipAttribution=)]
    2018-08-24 一天没事干

    很好的学习机会

    0

相关资讯

Sci Rep:体重对前列腺癌患者术后肿瘤治疗结果的影响

在根治性前列腺切除术(RP)后前列腺癌(PCa)肿瘤治疗的不良临床结果中,肥胖(通常用更高的身体质量指数(BMI)来代表)作为一种潜在的风险因子还没有完全的阐释。最近,有研究人员在RP患者中评估了BMI与无生化复发(BCR)之间的关系。研究人员回顾性的分析了2006年到2007年之间经历RP的2997名PCa患者,并根据WHO推荐的亚洲男性BMI标准将其分成了3个小组:正常体重(<23kg/

盘点:前列腺癌相关治疗研究进展

前列腺癌是指发生在前列腺的上皮性恶性肿瘤。2004年WHO《泌尿系统及男性生殖器官肿瘤病理学和遗传学》中前列腺癌病理类型上包括腺癌(腺泡腺癌)、导管腺癌、尿路上皮癌、鳞状细胞癌、腺鳞癌。其中前列腺腺癌占95%以上,因此,通常我们所说的前列腺癌就是指前列腺腺癌。梅斯医学小编整理了近期前列腺癌的研究进展,与大家一起分享学习!【1】Sci Rep:利用Gd标签的红细胞产生的多参数MRI图谱来阐释前列

Clin Cancer Res:前列腺癌液体活检样本的单细胞分析

研究表明,循环肿瘤细胞(CTCs)具有临床相关性,但是由于它们出现的频率低,限制了人们对它的研究。最近,有研究人员通过清血法(Ahperesis)来增加CTC的产量,对患有转移性性前列腺癌的患者进行了液体活检评估,并进行了精确的基因拷贝数计算和疾病遗传与异质性研究。研究发现,清血法具有良好的耐受性,并且能够分离大量的CTCs细胞;从7.5mls患者外周血中获得的CTC细胞平均产量为167个,而每次

Cancer Causes Control:糖尿病、前列腺特异性抗原筛选与前列腺癌之间的关系研究

研究发现,患有糖尿病的男性前列腺风险(PCa)降低,可能是由于更低的前列腺特异性抗原(PSA)水平或者肿瘤生长抑制检测偏倚所致。理解是否更低的PCa患病率是由于疾病更低的风险或者是PSA检测偏倚引起,能够在前列腺筛选时帮助进行判断结果的好坏。研究人员利用来源自前列腺,肺,结直肠和卵巢(PLCO)的数据筛选试验来评估PSA筛选对患有糖尿病PCa男性的影响以及检测偏倚和/或更低肿瘤生长速度的潜在作用。

J Biol Chem:异位成纤维细胞生长因子受体1在前列腺癌细胞中能够促进炎症

在前列腺癌(PCa)进展过程中,成纤维生长因子受体1(FGFR1)起始表达的同时FGFR2表达缺失已经研究的比较多。尽管一些FGFR异构体能够在细胞增殖和生存中具有优势,而不同的FGFR异构体具体是通过怎样的机制来导致PCa的进展仍旧没有完全的理解。最近,有研究人员报道了成纤维生长因子(FGF)在PCa细胞中能够促进NF-κB信号,并且该信号与FGFR1的表达相关。FGFR1激酶活性的丧失在PCa

盘点:前列腺癌相关机理进展

前列腺癌是指发生在前列腺的上皮性恶性肿瘤。2004年WHO《泌尿系统及男性生殖器官肿瘤病理学和遗传学》中前列腺癌病理类型上包括腺癌(腺泡腺癌)、导管腺癌、尿路上皮癌、鳞状细胞癌、腺鳞癌。其中前列腺腺癌占95%以上,因此,通常我们所说的前列腺癌就是指前列腺腺癌。梅斯医学小编整理了近期前列腺癌的研究进展,与大家一起分享学习!【1】Prostate:在前列腺癌中,MCM10的过表达能够促进细胞的增殖